The store will not work correctly when cookies are disabled.
N-p-tolylpyrazine-2-carboxamide
ID: ALA454549
PubChem CID: 746705
Max Phase: Preclinical
Molecular Formula: C12H11N3O
Molecular Weight: 213.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(NC(=O)c2cnccn2)cc1
Standard InChI: InChI=1S/C12H11N3O/c1-9-2-4-10(5-3-9)15-12(16)11-8-13-6-7-14-11/h2-8H,1H3,(H,15,16)
Standard InChI Key: KJVVRLJAZVEKDF-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
3.7277 -4.8416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7266 -5.6690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4414 -6.0819 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1578 -5.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1550 -4.8380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4396 -4.4289 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8679 -4.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5839 -4.8326 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8648 -3.5978 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2968 -4.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0112 -4.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7237 -4.4162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7210 -3.5903 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0000 -3.1807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2905 -3.5975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4334 -3.1741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 1 0
7 9 2 0
4 5 1 0
8 10 1 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
13 16 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 213.24 | Molecular Weight (Monoisotopic): 213.0902 | AlogP: 2.04 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 1.53 | CX LogD: 1.53 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.83 | Np Likeness Score: -2.06 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |
2. PubChem BioAssay data set, |